Further characterization of the binding properties of a GalNAc specific lectin from Codium fragile subspecies tomentosoides

Previous study on the binding properties of a lectin isolatedfrom Codium fragile subspecies tomentosoides (CFT) indicatesthat this lectin recognizes the GalNAc1 sequence at both reducingand nonreducing ends. In this study, the carbohydrate specificityof CFT was further characterized by quantitative precipitin(QPA) and inhibition of lectin-enzyme binding assays. Of theglycoforms tested for QPA, all asialo-GalNAc1 containing glyco-proteinsreacted well with the lectin. Asialo hamster and ovine submandibularglycoproteins, which contain almost exclusively Tn (GalNAclSer/Thr)residues as carbohydrate side chains, and Streptococcus typeC polysaccharide completely precipitated the lectin added, whilethe GalNAcβcontaining Tamm-Horsfall Sd(a⁺) glycopro-teinand its asialo product were inactive. Among the oligo-saccharidestested for inhibiting lectin-glycoprotein interaction, GalNAc13GalNAcβ13Gal14Galβ14GIc(Fp)and Galβ13GalNAc1benzyl (T) were the best, and about 125-foldmore active than GalNAc They were about 3.3, 6.6, and 43 timesmore active than Tn containing glycopeptides, GalNAc13(LFuc12)Gal(A_h) and Galβ13GalNAc(T), respectively. From the presentand previous results, it is concluded that the combining siteof CFT is probably of a groove type that recognizes from GalNAclto pentasaccharide(Fp). The carbohydrate specificity of thislectin can be constructed and summarized in decreasing orderby lectin determinants as follows: Fp and T > Tn cluster> A_h >>I/II. carbohydrate specificities Codium fragile tomentosoides glycoprotein binding lectins     

A novel alpha1,2-fucosyltransferase (CE2FT-2) in Caenorhabditis elegans generates H-type 3 glycan structures

The 1,2-fucosyltransferase family (1,2FT) is the largest familyof glycosyltransferases in the genome of the free-living nematodeCaenorhabditis elegans, and early evidence suggests that eachmember may have a unique activity. Here we describe a C. elegansgene (designated CE2FT-2) encoding an 1,2FT that has the potentialto generate the sequence Fuc1-2Galβ1-3GalNAc-R, which isthe H-type 3 blood group structure. The CE2FT-2 cDNA encodesa putative transmembrane protein that shows 42% amino acid identityto a previously cloned C. elegans 1,2FT (termed CE2FT-1), buthas a very low identity (16–20%) to 1,2FT sequences inhumans, rabbits, and mice. A recombinant form of CE2FT-2 expressedin human 293T cells has a high 1,2FT activity toward Galβ1-3GalNAc-O-pNP,but unexpectedly, the enzyme is inactive toward the acceptorGalβ-O-phenyl. Thus, CE2FT-2 differs from all other 1,2FTspreviously described from animals that all utilize Galβ-O-phenyl.CE2FT-2 is expressed at all stages of worm development, butremarkably, promoter analysis of the CE2FT-2 gene using greenfluorescent protein reporter constructs indicates that the CE2FT-2is expressed exclusively in pharyngeal cells of the worm fromembryo to an adult stage. Because pharyngeal cells are knownto secrete their glycoconjugates to the nematode surface, theseresults may indicate that products of CE2FT-2 contribute tointeractions of the nematode with its environment or are usedas ligands for bacterial attachment. These findings, along withthose on other 1,2FTs in C. elegans, suggest that each 1,2FTin this organism may have a unique acceptor specificity, expressionpattern, and biological function.     

Phosphorylation and subcellular location of {alpha}-L-fucosidase in Iymphoid cells from patients with I-cell disease and pseudo-Hurler polydystrophy

Mannose 6-phosphate is a recognition marker used by many newlymade acid hydrolases for their transport to lyso-somes. Previously,we investigated the incorporation of ³²Pi into -L-fucosidaseof lymphoid cell lines from a healthy individual (control) andan I-cell disease patient [DiCioccio and Miller, Glycobiology,1, 595–604 (1991)]. Phosphoserine was found in immunoprecipitable-L-fucosidase of both control and I-cell lymphoid cells, butmannose 6-phosphate was identified only in enzyme of controlcells. Extension of this investigation to lymphoid culturesof a pseudo-Hurler polydystrophy patient also identified onlyphosphoserine in -L-fucosidase. Using [³H] mannose instead of³²Pi, the precise identification of mannose 6-phosphate in -L-fucosidaseof control cells, and its absence in -L-fucosidase of I-celland pseudo-Hurler cells, was established. The stoichiometryof phosphorylation of -L-fucosidase in I-cell, pseudo-Hurlerand control lymphoid cells was 3, 4 and 10 mol Pi/mol enzyme,respectively. -L-Fucosidase was located in lysosomes isolatedfrom control, I-cell and pseudo-Hurler lymphoid cells by subcelluarfractionation on Percoll density gradients. Both I-cell andpseudo-Hurler lymphoid cells displayed normal intralysosomalactivity of -L-fucosidase despite lack of the mannose 6-phosphatemarker. Thus, I-cell and pseudo-Hurler lymphoid cells must possessa mannose 6-phosphate-independent mechanism for directing -L-fucosidaseto lysosomes. Phosphorylation of -L-fucosidase in pseudo-Hurlerand I-cell lymphoid cultures was found almost exclusively inintracellular and not in extracellular enzyme, suggesting thatphosphoserine may participate in the localization of -L-fucosidasein lysosomes of these cells. -L-fucosidase I-cell disease lysosome phosphorylation pseudo-Hurler polydystrophy     

Sialylation of n-alkyllactosides, galactosides and glucosides by sialyltransferases from rat liver Golgi vesicles

nAlkyl - and -lactosides, galactosides and glucosides with differentalkyl chain lengths (C₂, C₈, C₁₄, and C₂₀) were synthesizedand used as acceptors for sialyltransferases from rat liverGolgi vesicles. The -galactosides, -glucosides, and both - and-lactosides, were sialylated. Keeping the acceptor concentrationconstant, sialylation rates reached a maximum for the n-octyl- and -lactosides, n-Octyl -galactoside and noctyl -glucoside,respectively. noctyl -glucoside, respectivwly. n-Octyl -galactosideand n-octyl -glucoside were not sialylated. The reaction productswere characterized by TLC. With n-octyl lactoside and galactosideas acceptors, two major sialylation products were formed. Thjeycould be separated by preparative TLC, and their structureswere identified as 2–3 and 2–6 sialylated acceptors,respectively, by a combination of periodated oxidation, NaBD₄reduction,permethylation and subsequent analysis by fast atombombardment mass spectrometry (FAB-MS). The structure of thesingle product obtained from n-ictyl -glucoside was determinedto be the 2–6 sialylated glucoside. Competition experimentswith n-octyl lactoside and lactosylceramide and gangliosideGal1-3GalNAc1-4(NeuAc2–3)Gal1–4Glcbeeta1–1Cer(GM1) as acceptors for sialyltransferases suggested that SAT-I[NeuAc2–3Gal1–4Glc1-1Cer (GM3) synthase] was atleast in least in part responsible for the 2–3 sialylationof n-octyl lactoside. alkylgalactosides alkylglucosides alkyllactosides neoglycolipids sialytransferases     

Biosynthesis, processing, and secretion of {alpha}-L-fucosidase in lymphoid cells from patients with I-cell disease and pseudo-Hurler polydystrophy

N-Acetylglucosamine 1-phosphotransferase is a key enzyme requiredfor synthesis of the mannose 6-phosphate recognition markerthat is used by many newly made acid hydrolases for their transportto lysosomes. It has previously been found that lymphoid cellsfrom patients with I-cell disease and pseudo-Hurler polydystrophyhave nearly normal intracellular and intralysosomal activitiesof several lysosomal acid hydrolases, despite a deficiency ofN-acetylglucosamine 1-phosphotransferase. These results suggestthat lymphoid cells may provide an important system to investigatealternate mechanisms for targeting newly made acid hydrolasesto lysosomes. In the present study, the biosynthesis, processingand secretion of -L-fucosidase in I-cell and pseudoHurler lymphoidcells was used as a model system to study the existence of suchmechanisms. The level of intracellular -L-fucosidase proteinin exponentially growing I-cell or pseudo-Hurler lymphoid cultureswas statistically indistinguishable from the mean of 19 controlcultures. A 1.5 h [³⁵S]methionine pulse experiment showed that-L-fucosidase is initially sythesized by I-cell, pseudo-Hurlerand control cultures as an intracellular form (M_r = 58 000).Companion cultures chased with methionine from 2 to 21 h processedthe enzyme to an intracellular form (M_r = 60 000) and an extracellularform (M_r = 62 000). All enzyme forms were glycoproteins withpolypeptide chains of Mr 52 000. In control cells incubatedwith radioactive inorganic phosphate (³²Pi), <1% of the ³²Piincorporated into -L-fucosidase was associated with carbohydratechains and >99% with polypeptide chains. In I-cell diseaselymphoid cells, the ³²Pi incorporated into -L-fucosidase wasassociated solely with polypeptide chains. A qualitative analysisof phosphorylated residues identified phosphoserine in -L-fucosidasefrom control and I-cell lymphoid cells. Only -L-fucosidase fromcontrol cells contained mannose 6-phosphate. These results areconsistent with the proposal that I-cell lymphoid cells mayuse a mannose 6-phosphate-independent mechanism for routing-L-fucosidase. Additional metabolic labelling experiments demonstratedthe presence of ³²P-labelled -L-fucosidase in both cells andmedium of a control lymphoid culture, but only in cells of anI-cell lymphoid culture. In contrast, -L-fucosidase labelledwith [³⁵S]methionine was found in cells and medium of controland I-cell lymphoid cultures. Since phosphoserine was only foundto occur in intracellular, but not in extracellular -L-fucosidaseof the I-cell culture, we speculate that phosphoserine may beinvolved in intracellular retention of -L-fucosidase in I-celllymphoid cells. -L-fucosidase I-cell disease lymphoid cells phos-phorylation pseudo-Hurler polydystrophy     

Reaction mechanism and substrate specificity for nucleotide sugar of mammalian alpha1,6-fucosyltransferase--a large-scale preparation and characterization of recombinant human FUT8

FUT8, mammalian 1,6-fucosyltransferase, catalyzes the transferof a fucose residue from the donor substrate, guanosine 5'-diphosphate(GDP)-ß-L-fucose, to the reducing terminal GlcNAcof the core structure of asparagine-linked oligosaccharide viaan 1,6-linkage. FUT8 is a typical type II membrane protein,which is localized in the Golgi apparatus. We have previouslyshown that two neighboring arginine residues that are conservedamong 1,2-, 1,6-, and protein O-fucosyltransferases play animportant role in donor substrate binding. However, detailsof the catalytic and reaction mechanisms and the ternary structureof FUT8 are not understood except for the substrate specificityof the acceptor. To develop a better understanding of FUT8,we established a large-scale production system for recombinanthuman FUT8, in which the enzyme is produced in soluble formby baculovirus-infected insect cells. Kinetic analyses and inhibitionstudies using derivatives of GDP-ß-L-fucose revealedthat FUT8 catalyzes the reaction which depends on a rapid equilibriumrandom mechanism and strongly recognizes the base portion anddiphosphoryl group of GDP-ß-L-fucose. These resultsmay also be applicable to other fucosyltransferases and glycosyltransferases.     

Treatment with the {alpha}-glucosidase 1 inhibitor 6-O-butanoyl castanospermine reduces the detection of LFA-1 (CD18/CD11a) by monoclonal antibodies

The antiviral clinical candidate 6-O-butanoyl castano-spermine(MDL 28,574), an -glucosidase 1 inhibitor, was examined forits effect on elementary parameters of immune function. It didnot affect the mitogenic response of uninfected human mononuclearleukocytes or the detection of a range of cell surface markers,with the exception of the integrin LFA-1 (CD18/CD11a), whichwas reduced, after cell growth in vitro. The detection of LFA-1was also reduced on both human and murine cells after oral administrationof the compound to xenochimaeric or normal mice, respectively.Altered LFA-1 expression or function may contribute to reducedcell adhesion and the observed reduction in the in vitro allogeneicresponse by uninfected cells, as well as the previously describedprevention of cell conjugate and HTV-induced syncytium formation. adhesion 6-O-butanoyl castanospermine CD18 CD11a LFA-1     

Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes

Neisseria meningitidis expresses a heterogeneous populationof lipooligosaccharide (LOS) inner cores variously substitutedwith 1-3-linked glucose and O-3, O-6, and O-7 linked phosphoethanolamine(PEA), as well as glycine, attached to HepII. Combinations ofthese attachments to the LOS inner core represent immunodominantepitopes that are being exploited as future vaccine candidates.Historically, each LOS immunotype was structurally assessedand prescribed a certain unique inner core epitope. We reportthat a single isolate, strain NMB, possesses the capacity toproduce all of the known neisserial LOS inner core immunotypestructures. Analysis of the inner cores from parental LOS revealedthe presence or absence of 1,3-linked glucose, O-6 and/or O-7linked PEA, in addition to glycine attached at the 7 positionof the HepII inner core. Identification and inactivation oflpt-6 in strain NMB resulted in the loss of both O-6 and O-7linked PEA groups from the LOS inner core, suggesting that Lpt-6of strain NMB may have bifunctional transferase activities orthat the O-6 linked PEA groups once attached to the inner coreundergo nonenzymatic transfer to the O-7 position of HepII.Although O-3 linked PEA was not detected in parental LOS innercores devoid of 1-3-linked glucose residues, LOS glycoformsbearing O-3 PEA groups accumulated in a truncated mutant, NMBlgtK(Hep₂Kdo₂-lipid A). Because these structures disappeared uponinactivation of the lpt-3 locus, strain NMB expresses a functionalO-3 PEA transferase. The LOS glycoforms expressed by NMBlgtKwere also devoid of glycine attachments, indicating that glycinewas added to the inner core after the completion of the -chainby LgtK. In conclusion, strain NMB has the capability to expressall known inner core structures, but in in vitro culture L2and L4 immunotype structures are predominantly expressed.     

Structure determination of the intact major sialylated oligosaccharide chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells

Recombinant human erythropoietin (rHuEPO) is used abundantlyin the clinic to stimulate red blood cell growth in anaemicpatients. The efficacy of the drug depends strongly on the extentof sialylation of its carbohydrate moiety. Prompted by conflictingliterature reports on the issue, we reinvestigated the structuresof the intact sialylated carbohydrate chains of rHuEPO expressedin Chinese hamster ovary (CHO) cells. The asparagine-linkedoligosaccharides were released from rHuEPO with N-glycanaseand fractionated by anion-exchange chromatography. The O-linkedoligosaccharides were released under alkaline borohydride conditions.The primary structures of the major sialylated N- and O-typeoligosaccharides were identified by 500-MHz ¹H-NMR spectroscopy,supported by data from composition analysis, methylation analysis,low- and high-pH anion-exchange chromatography, and fast atombombardment-mass spectrometry. The mod abundant N-linked oligosaccharidesin CHO cell-derived rHuEPO were found to be di-antennary, 2,4-branchedtri-antennary, 2,6-branched tri-antennary and tetra-antennarychains (in the ratio of 7:6:5:82), with the latter containingbetween zero and three repeating N-acetyllactosamine units,in well-defined branches. The major (>95%) di-, tri- andtetra-antennary structures are fully sialylated, i.e. they havetwo, three and four sialic acid residues, respectively, Linkedexclusively (23) to galactose residues. The majority (>95%)of N-Linked structures contain (16)-linked fucose at the proximalGlcNAc residue. The O-type mono- and disialyl oligosaccharideswere characterized as a linear tri- and a branched tetra-saccharide,respectively. erythropoietin FAB-MS ¹H-NMR recombinant glycoprotein sialic acid     

Purification and Partial Characterization of a Lectin from the Bark of Japanese Elderberry (Sambucus sieboldiana)

A lectin [Sambucus sieboldiana agglutinin (SSA)] was purifiedfrom the twigs of Sambucus sieboldiana by repeated affinitychromatography on fetuin-Sepharose. SSA had a molecular weight(Mr) of approximately 160 K on gel filtration and consistedof two types of subunit of which the molecular weights rangedfrom 31 to 37 K. SSA agglutinated human erythrocytes irrespectiveof their blood type and the hemagglutination was inhibited bya very low concentration of Neu5Ac(2-6)lactose, suggesting thatSSA has a carbohydrate-binding specificity similar to that ofthe lectin previously isolated from the bark of S. nigra (SNA).However, the Ouchterlony double-diffusion analysis of theselectins with an antibody raised against SSA showed that SSAwas immunologjcally related but not identical to SNA. (Received January 17, 1989; Accepted June 19, 1989)     

Purification and characterization of an O-acetylsialic acid-specific lectin from a marine crab Cancer antennarius

A sialic acid-binding lectin with high specificity for 9-O-acetyl- and 4-O-acetylsialic acids was purified from the hemolymph of the California coastal crab, Cancer antennarius, by affinity chromatography using bovine submaxillary mucin coupled to agarose. The binding specificity of the crab lectin distinguishes it from other known sialic acid-specific lectins from Limulus polyphemus and Limax flavus which show a broader range of specificity for sialic acids. The purified lectin is homogenous on sodium dodecyl sulfate-polyacrylamide electropherograms with a subunit molecular weight of about 36 kDa. The specificity of the lectin for O-acetylsialic acids appears to account for the fact that it agglutinates mouse, rat, rabbit, and horse erythrocytes, which contain O-acetylsialic acids on cell surface glycoconjugates, but not human monkey, sheep, goat, and chicken erythrocytes which contain only NeuAc or N-glycolylneuraminic acid (NeuGc). This conclusion was supported by the potent inhibition of hemagglutination by bovine and equine submaxillary mucins which contain 9(7,8)-O-acetyl- and 4-O-acetylsialic acids, respectively, and also by free 9-O-acetyl-N-acetylneuraminic acid (9-O-Ac-NeuAc) and 4-O-Ac-NeuAc relative to NeuAc and NeuGc. Further support for the role of O-Ac-sialic acids in hemagglutination of erythrocytes was obtained by enzymatic modification of human erythrocytes. Sialidase-treated erythrocytes were resialylated with purified sialyltransferases and various CMP-sialic acid donor substrates to contain NeuAc or NeuGc or 9-O-Ac-NeuAc in the Sia alpha 2,3Gal or Sia alpha 2,6Gal linkages. Cells resialylated to contain NeuAc or NeuGc were not agglutinated, but cells resialylated to contain 9-O-Ac-NeuAc were agglutinated with high titer, comparable to that of mice or horse erythrocytes.     

TNF-alpha is a mitogen in skeletal muscle

Emerging evidence suggests that tumor necrosis factor (TNF)- plays a role in muscle repair. To determine whether TNF- modulates satellite cell proliferation, the current study evaluated TNF- effects on DNA synthesis in primary myoblasts and on satellite cell activation in adult mouse muscle. Exposure to recombinant TNF- increased total DNA content in rat primary myoblasts dose-dependently over a 24-h period and increased the number of primary myoblasts incorporating 5-bromo-2'-deoxyuridine (BrdU) during a 30-min pulse labeling. Systemic injection of TNF- stimulated BrdU incorporation by satellite cells in muscles of adult mice, whereas no BrdU was incorporated by satellite cells in control mice. TNF- stimulated serum response factor (SRF) binding to the serum response element (SRE) present in the c-fos gene promoter and stimulated reporter gene expression controlled by the same element. Our data suggest that TNF- activates satellite cells to enter the cell cycle and accelerates G₁-to-S phase transition, and these actions may involve activation of early response genes via SRF. cytokine; cell cycle; satellite cells; serum response factor; c-fos     

Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells

Free, monovalent SLeX (Neu5Ac2-3GalßI-4(Fucl-3)-GlcNAc),SLn (Neu5Ac2-3Galß1-4GlcNAc) and corresponding BSA-conjugatedforms—displaying different ratios of SLeX and SLn to protein—weretested for their ability to inhibit binding of HL-60 cells toImmobilized E-selectin. Free SLeX and conjugated SLeX-BSA inhibitedcell binding in a dose-dependent manner. SLn and SLn-BSA didnot inhibit binding. SLeX₁₆BSA (16 mol tetrasaccharide/mol BSA)and monovalent SLeX inhibited cell binding with measured inhibitoryconcentrations (IC₅₀s) of 1 µM and 1 mM, respectively,demonstrating a three-order-of-magnitude enhancement of inhibitoryactivity with the multivalent form of SLeX. A SLex₇BSA conjugatewas 10-fold less potent than those with 11 or 16 mol SLeX/molBSA. An assay which measured neutrophil rolling on interleukin(IL)-1ß-activated human umbilical vein endothelialcells (HUVECs) showed 50% reduction in the number of rollingneutrophils in the presence of 1 µM SLeX₁₆BSA, whereasthe level of free, monovalent SLeX oligosaccharide requiredto produce the same effect was {small tilde}0.3 mM. SLeX–BSAwas found to be an excellent reagent for staining endothelialcells expressing E-selectin. Biotinylated SLeX–BSA inconjunction with Texas red avidin-stained lipopolysaccharide(LPS)-activated HUVECs, and co-incubation of activated cellswith anti-E-selectin, specifically blocked staining. The distributionof E-selectin, as determined by binding of SLeX–BSA, wasvirtually identical with that obtained by binding of anti-E-selectinantibody. The pattern was punctate in nature, rather than beingdiffuse, suggesting that E-selectin may be organized as clusterswithin the plasma membrane. The results suggest that multivalentforms of SLeX bind to E-selectin with higher affinity than domonovalent glycans. Clustering of E-selectin in the membranemay be important for binding to counter-receptors on leukocytecell surfaces. cell adhesion E-selectin glycoconjugate leukocyte receptors sialyl-LeX     

Mycobacterial arabinan biosynthesis: the use of synthetic arabinoside acceptors in the development of an arabinosyl transfer assay

Information on the biosynthesis of the D-arabinans of the cellwall of Mycobacterium tuberculosis is rapidly emerging, withthe promise of new targets for drug development against tuberculosis.Accordingly, arabinosyl transferase assays were developed utilizingsynthesized [1–¹⁴C]-β-D-arabinofuranosyl-1-monophosphoryldecaprenolas donor and a variety of O- and S-alkyl arabinosides as acceptors.These were: -D-Araf-(15)--D-Araf-O- and -S-alkyl di-arabinosidesand -D-Araf-(15)--D-Araf-(15)--D-Araf-O- and -S-alkyl triarabinosides.Whereas the O- and S-alkyl monosaccharide acceptors were inactive,the O- and S-alkyl disaccharide and the O- and S-alkyl trisaccharideacceptors (<C12) possessed considerable acceptor activity,and the trisaccharide acceptors were more potent than the correspondingdisaccharides. The O-alkyl disaccharide acceptors with a C8alkyl chain were more active than those containing the C6 orC10 analogs. Chemical analysis of the enzymatically synthesizedproducts of the reactions demonstrated that β-D-arabinofuranosyl-1-monophosphoryldecaprenolwas an effective donor for two of the three potential arabinosyltransferases: β-D-arabinofuranosyl-1-monophosphoryldecaprenol:arabinan (15) arabinosyl transferase and β-D-arabinofuranosyl-1-monophosphoryl-decaprenol:arabinan β(12) arabinosyl transferase. The β(12) arabinosyltransferase activity was more in evidence in the presence ofthe O-alkyl disaccharide acceptor, whereas both transferaseswere about equivalent in the presence of the S-alkyl trisaccharideacceptor. The tuberculosis drug, ethambutol, a known mycobacterialarabinosyl transferase inhibitor, was inactive within thesearabinosyl transferase/acceptor based assay systems, supportingother evidence that a third activity, responsible for the formationof 13 linkage, is the drug target. acceptor arabinan biosynthesis glycosyltrans-ferase assay mycobacteria     

Externalization and binding of galectin-1 on cell surface of K562 cells upon erythroid differentiation

Galectin 1 (GAL1) is a β-galactoside-binding lectin involvedin cell cycle progression. GAL1 overexpression is associatedwith neoplastic transformation and loss of differentiation.The gene encoding for human GAL1 resides on chromosome 22(ql2;ql3), and its expression is devel-opmentally regulated. Althoughdevoid of signal peptide GAL1 can be externalized from cellsby a mechanism independent of the normal secretory process.We report here on a study of the effects of erythroid differentiationof the human leukemia cell line K562 on GAL1 protein expression.In undifferentiated K562 cells, GAL1 was expressed into thecytosol. However, the amount of GAL1 was surprisingly weakerin K562 cells than in other leukemia cell lines such as TF-1or KGla. Treatment of K562 cells with erythropoietin (EPO) orwith aphidicolin (APH), an inhibitor for DNA polymerase , inducedan erythroid pheno-type and led to the externalization of cytosolicGAL1 which was then bound to ligands on cell surface in a galactoside-inhibitablefashion. Our results demonstrate that acquisition of an erythroidphenotype is associated with an exter-nalization of GALL Theautocrine binding of GAL1 to cell surface ligands of non adherentcells such as K562 suggest that GAL1 is implicated rather insignal transduction than in cell-cell or cell-matrix interaction.Moreover, the reciprocal translocation involving chromosomes9 and 221(9;22) present in K562 cells might explain the weakexpression of GAL1 in K562 leukemia cells. galectin-l K562 cells differentiation glycoconjugates     

LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation

Schistosomes, major parasitic helminths, express numerous glycoconjugatesthat provoke humoral and cellular immune responses in the infectedhuman host. The main pathology in schistosomiasis is due tothe formation of granulomas around tissue-trapped eggs and theresulting organ damage. By using a mouse model of inductionof granulomas by hepatic implantation of antigen-coated beads,it has been determined that the glycan part of schistosomalsoluble egg antigens (SEA) initiates granulomogenesis. To identifywhich individual glycan elements in this complex SEA mixtureare granulomogenic, we have tested in the same mouse model conjugatesof various synthetic oligosaccharides characteristic for schistosomeeggs, including GalNAcß1-4GlcNAc (LacdiNAc, LDN),Galß1-4(Fuc1-3)GlcNAc (Lewis^x), Fuc1-2Fuc1-3GlcNAc(DF-Gn), and Fuc1-3GalNAcß1-4(Fuc1-3)GlcNAc (F-LDN-F).Ribonuclease (RNase) A and B, and different fetuin glycoformswere included as controls. Only beads that carry glycoconjugateswith terminal LacdiNAc or Galß1-4GlcNAc (LacNAc, LN)elements gave rise to granulomas, with macrophage, lymphocyte,and eosinophil levels similar to the granulomatous lesions causedby schistosome eggs in a natural infection. Uncoated beads,and beads coated with fucosylated glycoconjugates or glycoconjugateslacking terminally exposed Gal or GalNAc, only attracted a monolayerof macrophages. These results indicate that the formation ofhepatic granulomas is triggered specifically by glycoconjugateswhich carry terminal LacNAc or LacdiNAc, both constituents ofthe schistosome egg.     

The role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading

Primary open angle glaucoma (POAG) is a major blindness-causingdisease, characterized by elevated intraocular pressure dueto an insufficient outflow of aqueous humor. The trabecularmeshwork (TM) lining the aqueous outflow pathway modulates theaqueous outflow facility. TM cell adhesion, cell–matrixinteractions, and factors that influence Rho signaling in TMcells are thought to play a pivotal role in the regulation ofaqueous outflow. In a recent study, we demonstrated that galectin-8(Gal8) modulates the adhesion and cytoskeletal arrangement ofTM cells and that it does so through binding to β₁ integrinsand inducing Rho signaling. The current study is aimed at thecharacterization of the mechanism by which Gal8 mediates TMcell adhesion and spreading. We demonstrate here that TM cellsadhere to and spread on Gal8-coated wells but not on galectin-1(Gal1)- or galectin-3 (Gal3)-coated wells. The adhesion of TMcells to Gal8-coated wells was abolished by a competing sugar,β-lactose, but not by a noncompeting sugar, sucrose. Also,a trisaccharide, NeuAc2-3Galβ1-4GlcNAc, which binds specificallyto the N-CRD of Gal8, inhibited the spreading of TM cells toGal8-coated wells. In contrast, NeuAc2-6Galβ1-4GlcNAc whichlacks affinity for Gal8 had no effect. Affinity chromatographyof cell extracts on a Gal8-affinity column and binding experimentswith plant lectins, Maakia Amurensis and Sambucus Nigra, revealedthat ₃β₁, ₅β₁, and _vβ₁ integrins are major counterreceptorsof Gal8 in TM cells and that TM cell β₁ integrins carrypredominantly 2-3-sialylated glycans, which are high-affinityligands for Gal8 but not for Gal1 or Gal3. These data lead usto propose that Gal8 modulates TM cell adhesion and spreading,at least in part, by interacting with 2-3-sialylated glycanson β₁ integrins.     

Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase

Trypanosoma cruzi, the agent of Chagas disease, expresses onits surface a trans-sialidase that catalyzes preferentiallythe transference of -2,3-linked sialic acid to acceptors containingterminal β-galactosyl residues, instead of the typicalhydrolysis reaction, found in most sialidases. The trans-sialidaseis responsible for the acquisition of the host sialic acid bythis protozoan parasite, which does not synthesize sialic acids.Here, we have studied some kinetic properties of a recombinanttrans-sialidase expressed in Escherichia coli We found thatit has sequential-type kinetics for the transferase reaction,as shown for the parasite-derived enzyme. The rates of sialicacid transfer to water (hydrolysis), and to β-galactosylresidues have a unique behavior with respect to the reactiontemperature. While the hydrolysis rate of sialyUactose increasescontinuously up to 35°C, the temperature for the maximalrate of trans-glycosylation depends on the acceptor concentration.At low acceptor concentrations the rate of trans-glycosylationis maximal at 13°C and independent of the amount of sialicacid donors. With increasing acceptor concentrations, maximalrates of trans-glycosylation are shifted to higher temperatures.This finding is explained by an 8-fold increase in the K_m forthe acceptor from 13°C to 33°C. Differences in hydrolysisand transfer rates were also obtained by using 4-methyl-umbelliferyl-N-acetyl-neuraminicacid. However, its hydrolysis rate is much higher than the rateof transference to lactose, suggesting that a long-lived enzyme-sialosylintermediate is not formed. In addition, lactose does not increasethe rate of methyl-umbelliferone release at any temperature,indicating that the rate limiting step is the aglycon release.Based on these results we propose that trans-glycosylation inT.cruzi sialidase is favored by the existence of a binding sitefor β-galactosyl residues, which accepts the new glycosidicbond as sialic acid is released from the donor. With increasingtemperature the affinity for the acceptor decreases, resultingin a concomitant increase in the rate of transfer to water,which, in turn, can be suppressed by increasing the acceptorconcentration. Trypanosoma cruzi sialidase kinetics reaction mechanism temperature     

Specificity of the binding site of the sialic acid-binding lectin from ovine placenta, deduced from interactions with synthetic analogues

The specificity of the sialic acid-binding lectin from ovine placenta was examined in detail by haemagglutination inhibition assays applying a panel of 32 synthetic sialic acid analogues. The carboxylic acid group is a prerequisite for the interaction with the lectin, the -anomer of the methyl glycoside is only a little more effective as an inhibitor than the -anomer and the most potent inhibitor was 9-deoxy-10-carboxylic acid Neu5Ac, followed by 4-oxo-Neu5Ac. In contrast to the majority of known sialic acid-binding lectins, the N-acetyl group of Neu5Ac is not indispensable for binding, neither is the hydroxyl group at C-9 since substitutions at this carbon atom are well tolerated. Furthermore, all sulfur-containing substituents at C-9 enhanced the affinity of the lectin. This is the first sialic acid-binding lectin found to strongly bind thio derivatives.